HUCH Comprehensive Cancer Center, building 2

Helsinki 00290

0 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Liposarcoma, Dedifferentiated, Neoplasms

Studies at this site

• Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed
• This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer — Completed